Efficacy and Safety of 9MW0813 in Subjects With Diabetic Macular Edema
Clinical trial NCT05324774 · UNKNOWN
Trial details
- NCT number
- NCT05324774
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-28
- Primary completion
- 2023-09-30
- Enrollment
- 346
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.